Effect of Renin-Angiotensin-Aldosterone System Triple Blockade on Non-Diabetic Renal Disease : Addition of an Aldosterone Blocker, Spironolactone, to Combination Treatment with an Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker

• FURUMATSU Yoshiyuki

  Department of Kidney Disease and Hypertension, Osaka General Medical Center

• NAGASAWA Yasuyuki

  Department of Nephrology, Osaka University Graduate School of Medicine

• TOMIDA Kodo

  Department of Kidney Disease and Hypertension, Osaka General Medical Center

• MIKAMI Satoshi

  Department of Kidney Disease and Hypertension, Osaka General Medical Center

• KANEKO Tetsuya

  Department of Kidney Disease and Hypertension, Osaka General Medical Center

• OKADA Noriyuki

  Department of Kidney Disease and Hypertension, Osaka General Medical Center

• TSUBAKIHARA Yoshiharu

  Department of Kidney Disease and Hypertension, Osaka General Medical Center

• IMAI Enyu

  Department of Nephrology, Osaka University Graduate School of Medicine

• SHOJI Tatsuya

  Department of Kidney Disease and Hypertension, Osaka General Medical Center

収録刊行物

• Hypertension research : clinical and experimental : official journal of the Japanese Society of Hypertension

  Hypertension research : clinical and experimental : official journal of the Japanese Society of Hypertension 31 (1), 59-67, 2008-01-01

キーワード

• spironolactone
• aldosterone
• angiotensin-converting enzyme inhibitor
• angiotensin II receptor blocker
• proteinuria

詳細情報

• CRID: 1570572700644276352
• NII論文ID: 10021261089
• NII書誌ID: AA10847079
• ISSN: 09169636
• Web Site: https://search.jamas.or.jp/link/ui/2008187541
• 本文言語コード: en
• データソース種別:
  • CiNii Articles